Four year clinical statistics of iridium-192 high dose rate brachytherapy

International Journal of Urology

Volumn 13, Issue 2, 2006, Pages 116-121

  Shigehara, Kazuyoshi ^a   Mizokami, Atsushi ^a   Komatsu, Kazuto ^a   Koshida, Kiyoshi ^a   Namiki, Mikio ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

External beam radiotherapy; High dose rate brachytherapy; Iridium 192; Prostate cancer

Indexed keywords

HORMONE; IRIDIUM 192; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CEREBELLUM INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DISEASE COURSE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; ILEUS; INCONTINENCE; INTERMETHOD COMPARISON; INTERSTITIAL RADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PERFORATION; PERITONEUM; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; STATISTICAL ANALYSIS; SURVIVAL RATE; URINE RETENTION;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TIME FACTORS;

EID: 33644838881     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01243.x     Document Type: Article

References (22)

1. Hinotsu S Akaza H Zenritsusengan no ekigaku JapJClinUrol 2003 57 151 6
2. Hull GW Rabbani F Abbas F et al. Cancer control with radical prostatectomy alone in 1000 consecutive patients JUrol 2002 167 528 34
3. Dugan TC Shipley WU Young RH et al. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels JUrol 1991 146 1313 16
4. Akakura K Isaka S Akimoto S et al. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities Urology 1999 54 313 18
5. Syed AM Puthawala A Sharma A et al. High-dose-rate brachytherapy in the treatment of carcinoma of the prostate Cancer Control 2001 8 511 21
6. Vicini F Vargas C Gustafson G Edmundson G Martinez A High dose rate brachytherapy in the treatment of prostate cancer World JUrol 2003 21 220 8
7. Stromberg J Martinez A Gonzalez J et al. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial IntJRadiatOncolBiolPhys 1995 33 161 71
8. Partin AW Kattan MW Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 1997 277 1445 51
9. Kasahara K Inoue K Karashima T et al. High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer Nippon Hinyokika Gakkai Zasshi 2001 92 572 8
10. Saito S Momma T Dokiya T Murai M Brachytherapy for prostate cancer in Japan IntJUrol 2001 8 S22 7
11. Egawa S Brachytherapy for prostate cancer: permanent seed implantation versus HDR temporary brachytherapy JapJUrolSurg 2004 17 293 9
12. Kitagawa Y Koshida K Mizokami A et al. Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy IntJUrol 2003 10 377 82
13. Lee WR Hanks GE Schultheiss TE Corn BW Hunt MA Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen - driven outcome analysis JClinOncol 1995 13 464 9
14. Zagars GK Pollack A Kavadi VS von Eschenbach AC Prostate-specific antigen and radiation therapy for clinically localized prostate cancer IntJRadiatOncolBiolPhys 1995 32 293 306
15. Pisansky TM Kahn MJ Rasp GM Cha SS Haddock MG Bostwick DG A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma Cancer 1997 79 337 44
16. Grills IS Martinez AA Hollander M et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds JUrol 2004 171 1098 104
17. Holm HH Juul N Pedersen JF Hansen H Stroyer I Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography JUrol 1983 130 283 6
18. Martinez AA Pataki I Edmundson G Sebastian E Brabbins D Gustafson G Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report IntJRadiatOncolBiolPhys 2001 49 61 9
19. Ragde H Blasko JC Grimm PD et al. Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up SeminSurgOncol 1997 13 438 43
20. Weyrich TP Kandzari SJ Jain PR Iodine 125 seed implants for prostatic carcinoma. Five- and ten-year follow-up Urology 1993 41 122 6
21. Deger S Boehmer D Turk I et al. High dose rate brachytherapy of localized prostate cancer EurUrol 2002 41 420 6
22. Kovacs G Galalae R Loch T et al. Prostate preservation by combined external beam and HDR brachytherapy in nodal negative prostate cancer StrahlentherOnkol 1999 175 Suppl. 2 87 8